NPM1 mutations (48% vs. 25%, <i>p</i> = 0.0002) and t(8;21) translocation (23.2% vs. 3.7%, <i>p</i> < 0.001) were enriched in the EMD-AML cohort. This evidence concerns the gene NPM1 and acute myeloid leukemia.